ClinicalTrials.govpublic full text
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
multiple myeloma, transplant, multiple myeloma patients undergoing transplant, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914411
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.